# Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma

> **NCT00746330** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 32 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Mometasone furoate/formoterol fumarate (MFF)
- **DRUG:** Formoterol fumarate 12 μg pMDI (F12M)
- **DRUG:** Formoterol fumarate 12 μg DPI (F12D)
- **DRUG:** Placebo to F12D
- **DRUG:** Placebo to F12M/MFF

## Key facts

- **NCT ID:** NCT00746330
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00746330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00746330, "Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00746330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*